Literature DB >> 17763997

Depression and osteoporosis: epidemiology and potential mediating pathways.

B Mezuk1, W W Eaton, S H Golden.   

Abstract

INTRODUCTION: There have been numerous studies examining the association between depression and bone mineral density (BMD), but the underlying nature of this relationship remains unclear. Independent of this association, there is a growing body of evidence that depression impacts the risk for fracture in older adults. This article reviews the current epidemiological evidence regarding comorbidity of depression, low bone mineral density, and fracture.
METHODS: A review of the literature on depression, depressive symptoms, low BMD, osteoporosis, and fracture using electronic databases.
RESULTS: We reviewed 20 studies of the association between depression and BMD and five reports of the relationship between depression and fractures. Potential mediating mechanisms (both physiological and behavioral) are discussed, as well as potential confounding influences (e.g., medication use).
CONCLUSIONS: Most studies support the finding that depression is associated with increased risk for both low BMD and fractures, but variation in study design, sample composition, and exposure measurement make comparisons across studies difficult. Researchers should be aware of potential confounders, such as medication use, that may influence results. Future research should focus on identifying mediating pathways and targets for intervention in the relationships between depression, low BMD, and fracture.

Entities:  

Mesh:

Year:  2007        PMID: 17763997      PMCID: PMC2776700          DOI: 10.1007/s00198-007-0449-2

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  94 in total

1.  Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture.

Authors:  Richard Hubbard; Paddy Farrington; Chris Smith; Liam Smeeth; Anne Tattersfield
Journal:  Am J Epidemiol       Date:  2003-07-01       Impact factor: 4.897

Review 2.  Neuroendocrinology of female aging.

Authors:  Habib U Rehman; Ewan A Masson
Journal:  Gend Med       Date:  2005-03

3.  Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth.

Authors:  Stuart J Warden; Alexander G Robling; Megan S Sanders; Michael M Bliziotes; Charles H Turner
Journal:  Endocrinology       Date:  2004-11-11       Impact factor: 4.736

4.  Urinary free cortisol excretion in depression.

Authors:  B J Carroll; G C Curtis; B M Davies; J Mendels; A A Sugerman
Journal:  Psychol Med       Date:  1976-02       Impact factor: 7.723

5.  Bone mineral density in premenopausal women with major depressive disorder.

Authors:  Kâzim M Yazici; Ayşen Akinci; Ayşegül Sütçü; Levent Ozçakar
Journal:  Psychiatry Res       Date:  2003-03-25       Impact factor: 3.222

6.  Depression and bone mineral density in a community sample of perimenopausal women: Geelong Osteoporosis Study.

Authors:  Felice N Jacka; Julie A Pasco; Margaret J Henry; Mark A Kotowicz; Seetal Dodd; Geoff C Nicholson; Michael Berk
Journal:  Menopause       Date:  2005 Jan-Feb       Impact factor: 2.953

7.  Bone mineral density and depression: a community study in women.

Authors:  R Coelho; C Silva; A Maia; J Prata; H Barros
Journal:  J Psychosom Res       Date:  1999-01       Impact factor: 3.006

8.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

9.  Reducing the risk for distal forearm fracture: preserve bone mass, slow down, and don't fall!

Authors:  Jennifer L Kelsey; Mila M Prill; Theresa H M Keegan; Heather E Tanner; Allan L Bernstein; Charles P Quesenberry; Stephen Sidney
Journal:  Osteoporos Int       Date:  2004-10-26       Impact factor: 4.507

10.  Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men.

Authors:  Elizabeth M Haney; Benjamin K S Chan; Susan J Diem; Kristine E Ensrud; Jane A Cauley; Elizabeth Barrett-Connor; Eric Orwoll; M Michael Bliziotes
Journal:  Arch Intern Med       Date:  2007-06-25
View more
  48 in total

1.  Comorbid chronic illness and the diagnosis and treatment of depression in safety net primary care settings.

Authors:  Chizobam Ani; Mohsen Bazargan; David Hindman; Douglas Bell; Michael Rodriguez; Richard S Baker
Journal:  J Am Board Fam Med       Date:  2009 Mar-Apr       Impact factor: 2.657

2.  Maintaining bone health in patients with multiple myeloma: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.

Authors:  Teresa S Miceli; Kathleen Colson; Beth M Faiman; Kena Miller; Joseph D Tariman
Journal:  Clin J Oncol Nurs       Date:  2011-08       Impact factor: 1.027

3.  An observational study of glucocorticoid-induced osteoporosis prophylaxis in a national cohort of male veterans with rheumatoid arthritis.

Authors:  L Caplan; A E Hines; E Williams; A V Prochazka; K G Saag; F Cunningham; E Hutt
Journal:  Osteoporos Int       Date:  2010-04-01       Impact factor: 4.507

4.  [Drug-induced osteopathies. Drugs, pathogenesis, forms, diagnosis, prevention and therapy].

Authors:  R Bartl; C Bartl; R Gradinger
Journal:  Orthopade       Date:  2009-12       Impact factor: 1.087

Review 5.  Non-conventional features of peripheral serotonin signalling - the gut and beyond.

Authors:  Stephanie N Spohn; Gary M Mawe
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-10       Impact factor: 46.802

6.  Rates of bone loss among women initiating antidepressant medication use in midlife.

Authors:  Susan J Diem; Kristine Ruppert; Jane A Cauley; YinJuan Lian; Joyce T Bromberger; Joel S Finkelstein; Gail A Greendale; Daniel H Solomon
Journal:  J Clin Endocrinol Metab       Date:  2013-09-03       Impact factor: 5.958

Review 7.  Depression, fracture risk, and bone loss: a meta-analysis of cohort studies.

Authors:  Q Wu; J Liu; J F Gallegos-Orozco; J G Hentz
Journal:  Osteoporos Int       Date:  2010-03-04       Impact factor: 4.507

8.  Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.

Authors:  Marc DE Hert; Christoph U Correll; Julio Bobes; Marcelo Cetkovich-Bakmas; Dan Cohen; Itsuo Asai; Johan Detraux; Shiv Gautam; Hans-Jurgen Möller; David M Ndetei; John W Newcomer; Richard Uwakwe; Stefan Leucht
Journal:  World Psychiatry       Date:  2011-02       Impact factor: 49.548

Review 9.  Brains, bones, and aging: psychotropic medications and bone health among older adults.

Authors:  Monique J Brown; Briana Mezuk
Journal:  Curr Osteoporos Rep       Date:  2012-12       Impact factor: 5.096

10.  Affective Disorders, Bone Metabolism, and Osteoporosis.

Authors:  Briana Mezuk
Journal:  Clin Rev Bone Miner Metab       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.